Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Gummesson

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|April 19, 2017
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetesAnders Gummesson, Elisabeth Nyman, Mikael Knutsson, et al.
Journal of Obesity & Metabolic Syndrome|March 24, 2020
Beta-Cell Function, Self-rated Health, and Lifestyle Habits in 64-Year-Old Swedish Women with Metabolically Healthy Obesity PhenotypeOla Hjelmgren, Anders Gummesson, Göran Bergström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Cellular & Molecular Biology Letters|July 22, 2008
Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissuePer-Arne Svensson, Britt G Gabrielsson, Margareta Jernås, et al.
Nature Communications|May 4, 2021
Next generation plasma proteome profiling to monitor health and diseaseWen Zhong, Fredrik Edfors, Anders Gummesson, et al.
Clinical Drug Investigation|October 2, 2014
Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjectsAnders Gummesson, Haiyan Li, Michael Gillen, et al.
Scientific Reports|September 27, 2024
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidomeElias Björnson, Dimitrios Samaras, Malin Levin, et al.
European Journal of Preventive Cardiology|March 28, 2024
Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular diseasePatrick Royer, Elias Björnson, Martin Adiels, et al.
Journal of the American Heart Association|March 21, 2025
Resource Efficient Screening for Primary Prevention of Coronary Heart Disease: A Proof-of-Concept Test in the MESA CohortEva Hagberg, Elias Björnson, Martin Adiels, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2025
Thigh Muscles and Metabolic Dysfunction-Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT-Microbiota StudyAmar Osmancevic, Anders Gummesson, Matthew Allison, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|April 19, 2017
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetesAnders Gummesson, Elisabeth Nyman, Mikael Knutsson, et al.
Journal of Obesity & Metabolic Syndrome|March 24, 2020
Beta-Cell Function, Self-rated Health, and Lifestyle Habits in 64-Year-Old Swedish Women with Metabolically Healthy Obesity PhenotypeOla Hjelmgren, Anders Gummesson, Göran Bergström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Cellular & Molecular Biology Letters|July 22, 2008
Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissuePer-Arne Svensson, Britt G Gabrielsson, Margareta Jernås, et al.
Nature Communications|May 4, 2021
Next generation plasma proteome profiling to monitor health and diseaseWen Zhong, Fredrik Edfors, Anders Gummesson, et al.
Clinical Drug Investigation|October 2, 2014
Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjectsAnders Gummesson, Haiyan Li, Michael Gillen, et al.
Scientific Reports|September 27, 2024
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidomeElias Björnson, Dimitrios Samaras, Malin Levin, et al.
European Journal of Preventive Cardiology|March 28, 2024
Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular diseasePatrick Royer, Elias Björnson, Martin Adiels, et al.
Journal of the American Heart Association|March 21, 2025
Resource Efficient Screening for Primary Prevention of Coronary Heart Disease: A Proof-of-Concept Test in the MESA CohortEva Hagberg, Elias Björnson, Martin Adiels, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2025
Thigh Muscles and Metabolic Dysfunction-Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT-Microbiota StudyAmar Osmancevic, Anders Gummesson, Matthew Allison, et al.
Pageof 7